|
QGEN
|
Qiagen N.V.
|
0.22%
|
US
|
NYSE
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
0.21%
|
US
|
NASDAQ
|
|
HSIC
|
Henry Schein, Inc.
|
0.21%
|
US
|
NASDAQ
|
|
CRL
|
Charles River Laboratories International, Inc.
|
0.21%
|
US
|
NYSE
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
0.19%
|
US
|
NASDAQ
|
|
UHS
|
Universal Health Services, Inc.
|
0.18%
|
US
|
NYSE
|
|
BIO
|
Bio-Rad Laboratories, Inc.
|
0.17%
|
US
|
NYSE
|
|
RGEN
|
Repligen Corporation
|
0.16%
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
0.16%
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
0.16%
|
US
|
NYSE
|
|
PEN
|
Penumbra, Inc.
|
0.16%
|
US
|
NYSE
|
|
XRAY
|
DENTSPLY International Inc.
|
0.14%
|
US
|
NASDAQ
|
|
MASI
|
Masimo Corporation
|
0.14%
|
US
|
NASDAQ
|
|
BRKR
|
Bruker Corporation
|
0.14%
|
US
|
NASDAQ
|
|
ACHC
|
Acadia Healthcare Company, Inc.
|
0.14%
|
US
|
NASDAQ
|
|
OGN
|
Organon & Co.
|
0.14%
|
US
|
NYSE
|
|
CHE
|
Chemed Corp
|
0.14%
|
US
|
NYSE
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
0.11%
|
US
|
NASDAQ
|